Arsenite and cadmium, but not chromium, induce NAD(P)H:quinone oxidoreductase 1 through transcriptional mechanisms, in spite of post-transcriptional modifications

Toxicology in Vitro

Volumn 22, Issue 5, 2008, Pages 1184-1190

  Elbekai, Reem H ^a   El Kadi, Ayman O S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; Aryl hydrocarbon receptor; Metals; NADP(H):quinone oxidoreductase 1

Indexed keywords

ARSENIC TRIOXIDE; CADMIUM; CHROMIUM; CYCLOHEXIMIDE; MESSENGER RNA; OXIDOREDUCTASE; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ARTICLE; CELL LINE; DNA TRANSCRIPTION; HALF LIFE TIME; NONHUMAN; PROTEIN STABILITY; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION;

ANIMALS; ARSENITES; CADMIUM CHLORIDE; CELL LINE, TUMOR; CHROMIUM COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; LIVER NEOPLASMS; NAD(P)H DEHYDROGENASE (QUINONE); PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; SODIUM COMPOUNDS; TRANSCRIPTION, GENETIC;

EID: 44749090222     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.03.010     Document Type: Article

References (39)

1. Aono J., Yanagawa T., Itoh K., Li B., Yoshida H., Kumagai Y., Yamamoto M., and Ishii T. Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts. Biochemical and Biophysical Research Communications 305 (2003) 271-277
2. Baek S.O., Field R.A., Goldstone M.E., Kirk P.W., Lester J.N., and Perry R. A review of atmospheric polycyclic aromatic hydrocarbons: sources, fate and behavior. Water, Air, and Soil Pollution 60 (1991) 279-300
3. Dor F., Dab W., Empereur-Bissonnet P., and Zmirou D. Validity of biomarkers in environmental health studies: the case of PAHs and benzene. Critical Reviews in Toxicology 29 (1999) 129-168
4. Elbekai R.H., and El-Kadi A.O. Modulation of aryl hydrocarbon receptor-regulated gene expression by arsenite, cadmium, and chromium. Toxicology 202 (2004) 249-269
5. 6+. Free Radical Biology and Medicine 39 (2005) 1355-1367
6. Elbekai R.H., and El-Kadi A.O. Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium. Toxicology Letters 172 (2007) 106-119
7. Ernster L. DT diaphorase. Methods in Enzymology 10 (1967) 309-317
8. Faraonio R., Vergara P., Di Marzo D., Pierantoni M.G., Napolitano M., Russo T., and Cimino F. p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. The Journal of Biological Chemistry 281 (2006) 39776-39784
9. Gelboin H.V. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiological Reviews 60 (1980) 1107-1166
10. Gingerich T.J., Feige J.J., and LaMarre J. AU-rich elements and the control of gene expression through regulated mRNA stability. Animal Health Research Reviews 5 (2004) 49-63
11. He X., Chen M.G., Lin G.X., and Ma Q. Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 × Keap1 × Cul3 complex and recruiting Nrf2 × Maf to the antioxidant response element enhancer. The Journal of Biological Chemistry 281 (2006) 23620-23631
12. Jaiswal A.K. Antioxidant response element. Biochemical Pharmacology 48 (1994) 439-444
13. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radical Biology and Medicine 36 (2004) 1199-1207
14. Joseph P., Xie T., Xu Y., and Jaiswal A.K. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer. Oncology Research 6 (1994) 525-532
15. Kedersha N., and Anderson P. Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochemical Society Transactions 30 (2002) 963-969
16. Kedersha N., Stoecklin G., Ayodele M., Yacono P., Lykke-Andersen J., Fritzler M.J., Scheuner D., Kaufman R.J., Golan D.E., and Anderson P. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. The Journal of Cell Biology 169 (2005) 871-884
17. Landi L., Fiorentini D., Galli M.C., Segura-Aguilar J., and Beyer R.E. DT-Diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function. Free Radical Biology and Medicine 22 (1997) 329-335
18. Li Y., and Jaiswal A.K. Human antioxidant-response-element-mediated regulation of type 1 NAD(P)H:quinone oxidoreductase gene expression. Effect of sulfhydryl modifying agents. European Journal of Biochemistry/FEBS 226 (1994) 31-39
19. Long II D.J., Waikel R.L., Wang X.J., Perlaky L., Roop D.R., and Jaiswal A.K. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Research 60 (2000) 5913-5915
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
21. Ma Q., Kinneer K., Bi Y., Chan J.Y., and Kan Y.W. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. The Biochemical Journal 377 (2004) 205-213
22. McMahon M., Itoh K., Yamamoto M., Chanas S.A., Henderson C.J., McLellan L.I., Wolf C.R., Cavin C., and Hayes J.D. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Research 61 (2001) 3299-3307
23. Monks T.J., and Jones D.C. The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. Current Drug Metabolism 3 (2002) 425-438
24. Mulcahy R.T., Wartman M.A., Bailey H.H., and Gipp J.J. Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. The Journal of Biological Chemistry 272 (1997) 7445-7454
25. Nebert D.W., and Duffy J.J. How knockout mouse lines will be used to study the role of drug-metabolizing enzymes and their receptors during reproduction and development, and in environmental toxicity, cancer, and oxidative stress. Biochemical Pharmacology 53 (1997) 249-254
26. Nioi P., and Hayes J.D. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutation Research 555 (2004) 149-171
27. Pi J., Qu W., Reece J.M., Kumagai Y., and Waalkes M.P. Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Experimental Cell Research 290 (2003) 234-245
28. Prochaska H.J., and Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Research 48 (1988) 4776-4782
29. Rivera S.P., Saarikoski S.T., and Hankinson O. Identification of a novel dioxin-inducible cytochrome P450. Molecular Pharmacology 61 (2002) 255-259
30. Rushmore T.H., and Pickett C.B. Glutathione S-transferases, structure, regulation, and therapeutic implications. The Journal of Biological Chemistry 268 (1993) 11475-11478
31. Siegel D., Bolton E.M., Burr J.A., Liebler D.C., and Ross D. The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant. Molecular Pharmacology 52 (1997) 300-305
32. Stewart D., Killeen E., Naquin R., Alam S., and Alam J. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. The Journal of Biological Chemistry 278 (2003) 2396-2402
33. Swanson H.I. DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation. Chemico-Biological Interactions 141 (2002) 63-76
34. Talalay P., and Dinkova-Kostova A.T. Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates. Methods in Enzymology 382 (2004) 355-364
35. Wang S., Leonard S.S., Ye J., Ding M., and Shi X. The role of hydroxyl radical as a messenger in Cr(VI)-induced p53 activation. American Journal of Physiology Cell Physiology 279 (2000) C868-C875
36. Wei Y.D., Tepperman K., Huang M.Y., Sartor M.A., and Puga A. Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. The Journal of Biological Chemistry 279 (2004) 4110-4119
37. Yang W.H., Yu J.H., Gulick T., Bloch K.D., and Bloch D.B. RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and stress granules. RNA (New York, NY) 12 (2006) 547-554
38. Zhang Y., Talalay P., Cho C.G., and Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 2399-2403
39. Zhang Y., Kensler T.W., Cho C.G., Posner G.H., and Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proceedings of the National Academy of Sciences of the United States of America 91 (1994) 3147-3150